Mazdutide
IBI362 · LY3305677
A dual GLP-1 and glucagon receptor agonist based on oxyntomodulin, studied in registered trials for weight management and glycemic control. Adding glucagon activity is intended to raise energy expenditure alongside the GLP-1 effect.
Tracking and educational reference only, on values you enter or import yourself. Not medical advice or a dosing recommendation.
Regulatory status
Investigational
This substance is under study in humans, typically under a regulatory authorization such as an Investigational New Drug application. Investigational describes a stage of research and nothing more: it does not mean approval is coming, and it does not indicate that effectiveness has been established.
A regulatory status describes paperwork, not safety. An approved compound can still be wrong for a given person, and an unapproved one is neither thereby dangerous nor thereby fine.
Half-life
Weekly administration in registered trials; no human PK in a public label. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Investigational; handling follows the study protocol rather than a public label.
References
- PubChem compound record
- Registered clinical trial programme
Read the source
Common questions
Mazdutide, answered plainly.
01What is Mazdutide?+
A dual GLP-1 and glucagon receptor agonist based on oxyntomodulin, studied in registered trials for weight management and glycemic control. Adding glucagon activity is intended to raise energy expenditure alongside the GLP-1 effect. It is also referred to as IBI362, LY3305677. It is listed here under GLP-1 / Metabolic as educational reference, which is not a recommendation to use it.
02Is Mazdutide FDA approved?+
Investigational. This substance is under study in humans, typically under a regulatory authorization such as an Investigational New Drug application. Investigational describes a stage of research and nothing more: it does not mean approval is coming, and it does not indicate that effectiveness has been established.
03What is the half-life of Mazdutide?+
Weekly administration in registered trials; no human PK in a public label. A half-life is an educational pharmacology figure describing how long the body takes to clear half of a substance. It is not a schedule and does not imply one.
04How is Mazdutide stored and handled?+
Investigational; handling follows the study protocol rather than a public label. Storage conditions come from a manufacturer's own label where one exists, and a compound with no approved label has no agency-reviewed handling instructions at all.
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.